ArticleCell biochemistry and biophysics2026
Host-Derived Proteomic Profiling of Human and Canine Mammary Tumor Xenografts Identifies Enrichment of Lipid Metabolism-Related Pathways.
Article in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is the most frequently diagnosed cancer in women worldwide and one of the most common malignancies in dogs. Notable clinical, hormonal and molecular similarities between both species suggest that dogs may serve as a valuable comparative oncology model. Alterations in lipid homeostasis and metabolism are closely associated with the acquisition of cancer hallmarks. In this study, a comparative proteomic analysis of murine host-derived proteins was performed in cell line-derived xenograft (CDX) models generated from human triple-negative breast cancer cell line (MDA-MB-231) and a canine mammary carcinoma cell line (CMT-U27). Using LC-MS/MS and species-resolved proteomics, tumor-associated changes in the host proteome were characterized across models. In total, 577 proteins were differentially identified in tumor tissues compared with healthy mammary gland samples in this interspecies CDX comparison, with 51.99% showing increased and 46.79% decreased relative abundance, while a small proportion displayed opposite regulation patterns between models. Functional enrichment analysis revealed that several biological processes were altered, including pathways related to lipid metabolism. Moreover, proteins involved in lipid pathways showed a moderate level of concordance between models (r > 0.6, Mann-Whitney U test p < 0.05). Overall, these findings provide a descriptive overview of host-derived proteomic alterations in interspecies mammary tumor CDX models and suggest that lipid metabolism-related pathways may be involved in tumor-associated microenvironmental changes. This study should be considered exploratory and hypothesis-generating, providing a basis for future studies incorporating orthogonal validation and controlled experimental designs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.